24 research outputs found

    Hazard ratio of hospitalisation and mortality from ischemic heart disease and stroke for self-rated health (SRH) adjusted for socio-demographic variables, behavioural risk factors, clinical risk factors for cardiovascular disease (CVD) in 7,279 men and 9,285 women aged 39–79 years without prevalent CVD in EPIC-Norfolk (1992–2007).

    No full text
    a<p><b>Socio-demographic risk factors</b>: Age, sex and education.</p>b<p><b>Behavioural risk factors:</b> Smoking, alcohol use, vitamin C intake and physical activity.</p>c<p><b>Clinical risk factors:</b> Total cholesterol, systolic blood pressure, BMI, history of diabetes and family history of myocardial infarction or stroke.</p>*<p><b>Based on small numbers: n = 3 of n = 260 participants with poor SRH had a fatal CVD event during follow-up.</b></p

    Distribution of socio-demographic, behavioural and clinical risk factors for cardiovascular disease (CVD) and CVD outcomes by self-rated health (SRH) score in 9,087 men and 11,827 women aged 39–79 years without prevalent CVD in EPIC-Norfolk (1992–2007).

    No full text
    <p>Distribution of socio-demographic, behavioural and clinical risk factors for cardiovascular disease (CVD) and CVD outcomes by self-rated health (SRH) score in 9,087 men and 11,827 women aged 39–79 years without prevalent CVD in EPIC-Norfolk (1992–2007).</p

    Survival curve for cardiovascular disease events by self-rated health score.

    No full text
    <p>Survival curve for the hospitalisation and mortality from ischemic heart disease or stroke by self-rated health (SRH) score in 7,279 men and 9,285 women aged 39–79 without previous cardiovascular disease in EPIC-Norfolk (1992–2007), fully adjusted for sociodemographic variables (age, sex and education), behavioural risk factors (smoking, alcohol use, vitamin C intake and physical activity) and clinical risk factors (total cholesterol, systolic blood pressure, BMI, history of diabetes and family history of myocardial infarction or stroke).</p

    Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study

    Get PDF
    <div><p>Background</p><p>Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations.</p><p>Methods and Findings</p><p>Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with Îł-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs.</p><p>Conclusions</p><p>These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class.</p></div

    HRs of T2D and 95% CIs per 1 SD increase in total and individual n-6 PUFAs (LA, GLA, EDA, DGLA, AA, DTA, and n-6 DPA): EPIC-InterAct study.

    No full text
    <p>Model 1: displayed as diamonds. Age as underlying time variable, and adjusted for centre, sex, physical activity (inactive, moderately inactive, moderately active, or active), smoking (never, former, or current), education level (none, primary school, technical or professional school, secondary school, or higher education), and BMI (continuous, kg/m<sup>2</sup>). Model 2: displayed as circles. Adjusted as in Model 1 + total energy intake (continuous, kcal/d), alcohol (none, >0–<6, 6–<12, 12–<24 and ≄24 g/d), and (continuous, g/d intake of) meat, fruit and vegetables, dairy products, and soft drinks. Model 3: Displayed as squares. Adjusted as in Model 2 + (continuous, g/d intake of) fish and shellfish, nuts and seeds, vegetable oil, olive oil, and margarine.</p
    corecore